Grant: Operating Grant
University of Calgary
$706,253.00
Biomarkers of Vascular Function and Integrity in Cerebral Amyloid Angiopathy: A Prospective Longitudinal Cohort Study
EF 2014-15
Résumé
Cerebral amyloid angiopathy is a brain disease caused by build up of a toxic protein, called beta-amyloid, in brain blood vessels. This disease causes about 20% of all bleeding strokes and about 7% of all dementia. However, doctors have trouble recognizing this disease and determining how bad it is. There are no treatments for this disease, so it is important to gain a better understanding of how it affects the brain in order to develop new treatments. In this project we propose to study ways in which the brain is damaged by cerebral amyloid angiopathy. We will study how this disease makes it harder for blood vessels to react normally. We will see whether iron builds up in the brain. We will see whether we can measure inflammation in patients with this disease. And we will see whether all of these things are associated with shrinkage of the brain and risk for memory problems.
Programme
Operating Grant
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
323378
Name
Smith Eric E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Biological and Clinical Aspects of Aging 2
Projecttitle
Biomarkers of Vascular Function and Integrity in Cerebral Amyloid Angiopathy: A Prospective Longitudinal Cohort Study
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$706,253
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Aging; Alzheimer'S Disease; Cerebral Amyloid Angiopathy; Intracerebral Hemorrhage; Magnetic Resonance Imaging
Abstract
Cerebral amyloid angiopathy is a brain disease caused by build up of a toxic protein, called beta-amyloid, in brain blood vessels. This disease causes about 20% of all bleeding strokes and about 7% of all dementia. However, doctors have trouble recognizing this disease and determining how bad it is. There are no treatments for this disease, so it is important to gain a better understanding of how it affects the brain in order to develop new treatments. In this project we propose to study ways in which the brain is damaged by cerebral amyloid angiopathy. We will study how this disease makes it harder for blood vessels to react normally. We will see whether iron builds up in the brain. We will see whether we can measure inflammation in patients with this disease. And we will see whether all of these things are associated with shrinkage of the brain and risk for memory problems.
Competitiondate
201503
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Smith, Eric E
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $706,253~ $0~